Streetbeat News

Equity Actions

XPOF

Xponential Fitness, Inc. (XPOF) announced the appointment of Brenda Morris as interim CEO, replacing Anthony Geisler following his indefinite suspension amid ongoing investigations by the SEC and the USAO. The company reaffirmed its guidance despite these developments.

Portfolio Pulse from Benzinga Newsdesk

May 10, 2024 | 7:03 pm

TRV

Analysts have diverse opinions on Travelers Companies (NYSE:TRV), with recent evaluations showing a mix of ratings from bullish to bearish. The average 12-month price target for TRV has been raised to $230.71, indicating a positive outlook. Analyst actions, including both upgrades and downgrades, reflect ongoing adjustments to their views based on the company's performance and market conditions. Travelers Companies, known for its broad range of commercial and personal insurance products, shows a positive revenue trend but faces challenges in net margin, ROE, ROA, and debt management.

Portfolio Pulse from Benzinga Insights

May 10, 2024 | 7:01 pm

ARGX

12 analysts have recently updated their ratings and price targets for argenx (NASDAQ:ARGX), showing a mix of bullish and bearish views. The average 12-month price target has been raised to $458.5, reflecting a 5.43% increase from the previous target. Analyst actions include maintaining, raising, and lowering ratings and price targets, indicating varied perceptions of argenx's market position. The company, known for its antibody engineering technology, has shown significant revenue growth but struggles with profitability and efficiency metrics.

Portfolio Pulse from Benzinga Insights

May 10, 2024 | 7:01 pm

BAYRY

GOOG

IBM

INTC

MSFT

NVDA

AI is significantly impacting the pharmaceutical industry, from drug discovery to marketing, with Alphabet Inc's Google DeepMind developing AlphaFold 3, an AI model that predicts the structure of biological molecules. McKinsey reports AI could generate $60 billion-$110 billion annually for the industry, speeding up drug discovery and development. Collaborations like Bayer AG and Google Cloud are developing AI solutions for healthcare. Key players include Nvidia, Intel, IBM, Google, GE, Microsoft, Medtronic, Micron Technology, Amazon Web Services, and Siemens Healthineers.

Portfolio Pulse from Vandana Singh

May 10, 2024 | 6:49 pm

VOYA

Voya Financial (NYSE:VOYA) has been the subject of recent analyst evaluations, with 5 analysts offering insights over the past three months. The consensus among them appears somewhat bullish, with all 5 giving it a 'Somewhat Bullish' rating. The average 12-month price target for VOYA has been raised to $85.4, indicating a positive outlook from the analysts. Key financial metrics such as revenue growth, net margin, ROE, and ROA have been highlighted, showing the company's strong market position and financial health.

Portfolio Pulse from Benzinga Insights

May 10, 2024 | 6:00 pm

GOOG

GOOGL

GRND

META

NFLX

PARA

RBLX

TTD

Today's session highlighted significant options activity for 10 Communication Services stocks, indicating varied sentiments across the board. Large transactions, or 'whale alerts', were noted for stocks like PARA, SE, GOOGL, GRND, META, NFLX, VZ, GOOG, RBLX, and TTD, with sentiments ranging from bullish to bearish. These movements provide insights into potential market directions and investor expectations.

Portfolio Pulse from Benzinga Insights

May 10, 2024 | 5:35 pm

AMZN

BABA

CAVA

MAR

NKE

PDD

SBUX

TSLA

Today's session highlighted unusual options activity for 10 consumer discretionary stocks, indicating significant whale alerts. These alerts, which include both bullish and bearish sentiments across various expiration dates, suggest potential trading opportunities based on the abnormal trading volumes and sentiments expressed through options on stocks like AMZN, TSLA, PDD, and others.

Portfolio Pulse from Benzinga Insights

May 10, 2024 | 5:35 pm

AAPL

AEIS

AMD

ARM

INTC

IOT

MARA

NVDA

SOUN

TSM

Today's session highlighted significant options activity for 10 Information Technology stocks, with most showing bearish sentiment except for AAPL which was bullish. Large transactions, known as whale alerts, were observed across various stocks including NVDA, INTC, TSM, AMD, ARM, SOUN, AAPL, MARA, AEIS, and IOT, indicating potential shifts in market dynamics.

Portfolio Pulse from Benzinga Insights

May 10, 2024 | 5:35 pm

HAE

Four analysts have recently updated their ratings on Haemonetics (NYSE:HAE), showing a unanimous somewhat bullish outlook with all four maintaining or raising their price targets, leading to an average target of $110.5. This reflects a positive shift from the previous average of $108.33. Haemonetics has shown strong financial performance with notable revenue growth, net margin, ROE, and ROA, despite a high debt-to-equity ratio. The company is recognized for its contributions to the medical products and solutions sector, particularly in blood and plasma component collection.

Portfolio Pulse from Benzinga Insights

May 10, 2024 | 5:01 pm

Recent analyst evaluations of Brookfield (NYSE:BN) show a mix of opinions, with a shift towards a more positive outlook in the last 30 days. The average 12-month price target for BN has increased to $50.38, up from $49.00. Analyst actions include adjustments to ratings and price targets, reflecting their current views on the company's performance and market position. Brookfield's financial performance indicates solid revenue growth but challenges in profitability, debt management, and asset utilization.

Portfolio Pulse from Benzinga Insights

May 10, 2024 | 5:01 pm